| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.778 | 0.004 | 0.778 | Spasmolytic | 0.665 0.008 CID_32414 | ||
| 0.699 | 0.003 | 0.699 | Sigma receptor agonist | 0.681 0.003 CID_32414 | ||
| 0.597 | 0.008 | 0.597 | GABA C receptor rho-3 antagonist | 0.59 0.009 CID_32414 | ||
| 0.584 | 0.006 | 0.584 | Psychostimulant | 0.568 0.007 CID_32414 | ||
| 0.545 | 0.009 | 0.545 | Anticonvulsant | 0.453 0.016 CID_32414 | ||
| 0.538 | 0.022 | 0.649 | 5 Hydroxytryptamine release stimulant | 0.649 0.01 CID_32414 | CID_32414 | |
| 0.546 | 0.037 | 0.546 | Analgesic | 0.488 0.053 CID_32414 | ||
| 0.505 | 0.004 | 0.505 | Acetylcholine M1 receptor antagonist | 0.392 0.006 CID_32414 | ||
| 0.494 | 0.008 | 0.494 | Anesthetic general | 0.36 0.022 CID_32414 | ||
| 0.46 | 0.005 | 0.46 | Cholinergic antagonist | 0.355 0.01 CID_32414 | ||
| 0.449 | 0.005 | 0.449 | Acetylcholine antagonist | 0.346 0.01 CID_32414 | ||
| 0.463 | 0.044 | 0.53 | Calcium channel L-type activator | 0.53 0.018 CID_32414 | CID_32414 | |
| 0.456 | 0.039 | 0.456 | Aldehyde oxidase inhibitor | 0.289 0.069 CID_32414 | ||
| 0.419 | 0.005 | 0.419 | Acetylcholine muscarinic antagonist | 0.302 0.009 CID_32414 | ||
| 0.414 | 0.006 | 0.414 | Anesthetic local | 0.26 0.018 CID_32414 | ||
| 0.411 | 0.004 | 0.411 | Sigma 1 receptor antagonist | 0.314 0.004 CID_32414 | ||
| 0.442 | 0.042 | 0.442 | Cholesterol antagonist | 0.361 0.06 CID_32414 | ||
| 0.396 | 0.005 | 0.396 | Sigma receptor antagonist | 0.311 0.005 CID_32414 | ||
| 0.436 | 0.057 | 0.436 | Histamine release inhibitor | 0.377 0.087 CID_32414 | ||
| 0.411 | 0.052 | 0.43 | Vasodilator, peripheral | 0.43 0.046 CID_32414 | CID_32414 | |
| 0.345 | 0.004 | 0.345 | Acetylcholine M2 receptor antagonist | 0.205 0.006 CID_32414 | ||
| 0.354 | 0.015 | 0.378 | Tyrosine 3 hydroxylase inhibitor | 0.378 0.011 CID_32414 | CID_32414 | |
| 0.335 | 0.004 | 0.335 | Dopamine uptake inhibitor | 0.257 0.005 CID_32414 | ||
| 0.358 | 0.044 | 0.448 | Calcium channel activator | 0.448 0.011 CID_32414 | CID_32414 | |
| 0.325 | 0.014 | 0.325 | Protein kinase stimulant | 0.314 0.015 CID_32414 | ||
| 0.315 | 0.017 | 0.315 | Cytidine deaminase inhibitor | 0.209 0.044 CID_32414 | ||
| 0.348 | 0.056 | 0.348 | Vasodilator, coronary | 0.346 0.057 CID_32414 | ||
| 0.307 | 0.015 | 0.307 | Amyloid beta precursor protein antagonist | 0.258 0.03 CID_32414 | ||
| 0.299 | 0.021 | 0.299 | Lipocortins synthesis antagonist | 0.288 0.023 CID_32414 | ||
| 0.293 | 0.015 | 0.293 | Antipruritic | 0.238 0.028 CID_32414 | ||
| 0.281 | 0.007 | 0.367 | GABA C receptor rho-2 antagonist | 0.367 0.004 CID_32414 | CID_32414 | |
| 0.261 | 0.009 | 0.261 | Acetylcholine nicotinic antagonist | 0.24 0.01 CID_32414 | ||
| 0.3 | 0.049 | 0.3 | Potassium channel (Voltage-sensitive) blocker | 0.273 0.058 CID_32414 | ||
| 0.289 | 0.041 | 0.289 | Gastrin inhibitor | 0.238 0.094 CID_32414 | ||
| 0.271 | 0.024 | 0.33 | Tumour necrosis factor antagonist | 0.33 0.013 CID_32414 | CID_32414 | |
| 0.245 | 0.005 | 0.245 | Acetylcholine muscarinic agonist | 0.172 0.008 CID_32414 | ||
| 0.366 | 0.134 | 0.403 | Ca2+/calmodulin-dependent protein kinase kinase A inhibitor | 0.403 0.098 CID_32414 | CID_32414 | |
| 0.234 | 0.005 | 0.234 | Acetylcholine M3 receptor antagonist | 0.174 0.009 CID_32414 | ||
| 0.246 | 0.018 | 0.246 | Antiadrenergic | 0.239 0.018 CID_32414 | ||
| 0.28 | 0.056 | 0.358 | 5 Hydroxytryptamine uptake stimulant | 0.358 0.023 CID_32414 | CID_32414 | |
| 0.24 | 0.018 | 0.24 | Adrenaline antagonist | 0.235 0.018 CID_32414 | ||
| 0.226 | 0.004 | 0.226 | Acetylcholine M1 receptor agonist | 0.156 0.007 CID_32414 | ||
| 0.228 | 0.008 | 0.228 | Analgesic, opioid | 0.186 0.01 CID_32414 | ||
| 0.233 | 0.02 | 0.233 | Calcium channel blocker | 0.215 0.025 CID_32414 | ||
| 0.215 | 0.005 | 0.215 | Acetylcholine M4 receptor antagonist | 0.141 0.012 CID_32414 | ||
| 0.213 | 0.004 | 0.213 | Acetylcholine release stimulant | 0.156 0.013 CID_32414 | ||
| 0.215 | 0.009 | 0.215 | Opioid kappa receptor antagonist | 0.153 0.016 CID_32414 | ||
| 0.218 | 0.011 | 0.218 | Calcium antagonist | 0.194 0.014 CID_32414 | ||
| 0.349 | 0.146 | 0.373 | Caspase 9 stimulant | 0.373 0.128 CID_32414 | CID_32414 | |
| 0.206 | 0.014 | 0.206 | Histamine H1 receptor antagonist | 0.102 0.04 CID_32414 | ||
| 0.227 | 0.036 | 0.227 | Cholinergic | 0.18 0.056 CID_32414 | ||
| 0.202 | 0.011 | 0.253 | 5 Hydroxytryptamine uptake inhibitor | 0.253 0.008 CID_32414 | CID_32414 | |
| 0.207 | 0.026 | 0.207 | Alpha adrenoreceptor antagonist | 0.156 0.036 CID_32414 | ||
| 0.322 | 0.141 | 0.435 | 5 Hydroxytryptamine release inhibitor | 0.435 0.058 CID_32414 | CID_32414 | |
| 0.25 | 0.075 | 0.25 | 5 Hydroxytryptamine 1E antagonist | |||
| 0.195 | 0.02 | 0.195 | Nav1.1 sodium channel blocker | 0.134 0.04 CID_32414 | ||
| 0.268 | 0.093 | 0.268 | Nootropic | 0.215 0.139 CID_32414 | ||
| 0.187 | 0.017 | 0.187 | Acetylcholine agonist | 0.157 0.024 CID_32414 | ||
| 0.184 | 0.017 | 0.184 | Opioid antagonist | 0.162 0.022 CID_32414 | ||
| 0.172 | 0.006 | 0.172 | Acetylcholine M5 receptor antagonist | 0.112 0.015 CID_32414 | ||
| 0.235 | 0.071 | 0.235 | Cyclic AMP phosphodiesterase inhibitor | 0.192 0.1 CID_32414 | ||
| 0.18 | 0.019 | 0.18 | Antineoplastic alkaloid | 0.143 0.029 CID_32414 | ||
| 0.246 | 0.085 | 0.246 | Cardiotonic | 0.197 0.122 CID_32414 | ||
| 0.177 | 0.017 | 0.177 | Alpha 1b adrenoreceptor antagonist | 0.116 0.03 CID_32414 | ||
| 0.17 | 0.014 | 0.307 | GABA C receptor rho-1 antagonist | 0.307 0.003 CID_32414 | CID_32414 | |
| 0.168 | 0.015 | 0.168 | Ca2+-transporting ATPase inhibitor | 0.152 0.038 CID_32414 | ||
| 0.177 | 0.03 | 0.177 | Nav1.6 sodium channel blocker | 0.149 0.055 CID_32414 | ||
| 0.261 | 0.117 | 0.261 | Apoptosis antagonist | 0.248 0.129 CID_32414 | ||
| 0.169 | 0.026 | 0.169 | Alpha 1 adrenoreceptor antagonist | 0.118 0.037 CID_32414 | ||
| 0.165 | 0.023 | 0.356 | GABA C receptor antagonist | 0.356 0.004 CID_32414 | CID_32414 | |
| 0.15 | 0.01 | 0.15 | Glutamate release inhibitor | 0.104 0.036 CID_32414 | ||
| 0.232 | 0.093 | 0.294 | Interleukin agonist | 0.294 0.051 CID_32414 | CID_32414 | |
| 0.179 | 0.041 | 0.249 | Alpha-N-acetylglucosaminidase inhibitor | 0.249 0.023 CID_32414 | CID_32414 | |
| 0.28 | 0.143 | 0.28 | 15-Lipoxygenase inhibitor | 0.229 0.183 CID_32414 | ||
| 0.271 | 0.135 | 0.274 | Calpain 2 inhibitor | 0.274 0.132 CID_32414 | CID_32414 | |
| 0.245 | 0.109 | 0.245 | Ca(v)3.3 blocker | 0.202 0.189 CID_32414 | ||
| 0.151 | 0.017 | 0.151 | Opioid mu receptor antagonist | 0.13 0.022 CID_32414 | ||
| 0.173 | 0.042 | 0.173 | Neurotrophic factor | 0.141 0.068 CID_32414 | ||
| 0.16 | 0.03 | 0.16 | Sphingosine 1-phosphate receptor 2 antagonist | 0.152 0.039 CID_32414 | ||
| 0.145 | 0.016 | 0.145 | Dopamine D1 antagonist | 0.071 0.039 CID_32414 | ||
| 0.14 | 0.016 | 0.14 | Alpha 1d adrenoreceptor antagonist | 0.096 0.024 CID_32414 | ||
| 0.164 | 0.041 | 0.169 | Sphingosine 1-phosphate receptor 5 antagonist | 0.169 0.035 CID_32414 | CID_32414 | |
| 0.163 | 0.04 | 0.163 | Nav1.3 sodium channel blocker | 0.116 0.078 CID_32414 | ||
| 0.129 | 0.008 | 0.129 | Dopamine transporter inhibitor | 0.122 0.008 CID_32414 | ||
| 0.208 | 0.088 | 0.208 | Potassium channel blocker | 0.169 0.117 CID_32414 | ||
| 0.184 | 0.064 | 0.213 | Succinate dehydrogenase inhibitor | 0.213 0.04 CID_32414 | CID_32414 | |
| 0.15 | 0.034 | 0.15 | Calcium channel (voltage-sensitive) blocker | 0.125 0.051 CID_32414 | ||
| 0.154 | 0.038 | 0.154 | Heat shock protein 70 antagonist | 0.13 0.123 CID_32414 | ||
| 0.152 | 0.038 | 0.152 | Alpha 2b adrenoreceptor antagonist | 0.131 0.05 CID_32414 | ||
| 0.139 | 0.025 | 0.139 | Acetylcholine M3 receptor agonist | 0.132 0.029 CID_32414 | ||
| 0.243 | 0.133 | 0.249 | Transcription factor NF kappa B inhibitor | 0.249 0.128 CID_32414 | CID_32414 | |
| 0.134 | 0.026 | 0.134 | Alpha 1a adrenoreceptor antagonist | 0.102 0.035 CID_32414 | ||
| 0.121 | 0.016 | 0.126 | Calcium channel L-type blocker | 0.126 0.014 CID_32414 | CID_32414 | |
| 0.227 | 0.122 | 0.227 | Hypoxia-inducible factor 1 alpha inhibitor | 0.187 0.169 CID_32414 | ||
| 0.12 | 0.016 | 0.155 | Granulocyte macrophage colony stimulating factor agonist | 0.155 0.005 CID_32414 | CID_32414 | |
| 0.121 | 0.017 | 0.121 | 5 Hydroxytryptamine 1D antagonist | 0.072 0.037 CID_32414 | ||
| 0.196 | 0.093 | 0.196 | HERG channel blocker | 0.168 0.112 CID_32414 | ||
| 0.114 | 0.013 | 0.114 | Acetylcholine M5 receptor agonist | 0.072 0.042 CID_32414 | ||
| 0.202 | 0.103 | 0.222 | Vasodilator | 0.222 0.088 CID_32414 | CID_32414 | |
| 0.138 | 0.038 | 0.138 | Alpha 2c adrenoreceptor antagonist | 0.104 0.062 CID_32414 | ||
| 0.151 | 0.054 | 0.151 | Acetylcholinesterase inhibitor | 0.107 0.094 CID_32414 | ||
| 0.104 | 0.007 | 0.111 | Nicotinic alpha3beta2 receptor antagonist | 0.111 0.006 CID_32414 | CID_32414 | |
| 0.112 | 0.016 | 0.14 | Adrenaline uptake inhibitor | 0.14 0.01 CID_32414 | CID_32414 | |
| 0.136 | 0.041 | 0.137 | Photosensitizer | 0.137 0.04 CID_32414 | CID_32414 | |
| 0.149 | 0.058 | 0.149 | Nav1.2 sodium channel blocker | 0.127 0.076 CID_32414 | ||
| 0.185 | 0.094 | 0.193 | 5 Hydroxytryptamine 3E antagonist | 0.193 0.076 CID_32414 | CID_32414 | |
| 0.117 | 0.027 | 0.117 | Phosphodiesterase 6D inhibitor | 0.102 0.048 CID_32414 | ||
| 0.159 | 0.07 | 0.159 | Diuretic | 0.131 0.094 CID_32414 | ||
| 0.098 | 0.009 | 0.098 | Potassium channel Kv1.3 blocker | 0.094 0.009 CID_32414 | ||
| 0.106 | 0.022 | 0.106 | Neuronal nicotinic receptor antagonist | 0.099 0.025 CID_32414 | ||
| 0.175 | 0.091 | 0.175 | Non-steroidal antiinflammatory agent | 0.166 0.098 CID_32414 | ||
| 0.2 | 0.117 | 0.317 | Superoxide dismutase inhibitor | 0.317 0.045 CID_32414 | CID_32414 | |
| 0.171 | 0.088 | 0.171 | Hepatoprotectant | 0.163 0.097 CID_32414 | ||
| 0.086 | 0.005 | 0.086 | Acetylcholine M4 receptor agonist | 0.039 0.015 CID_32414 | ||
| 0.169 | 0.087 | 0.169 | DNA methyltransferase I inhibitor | |||
| 0.177 | 0.098 | 0.177 | Glyceraldehyde-3-phosphate dehydrogenase inhibitor | |||
| 0.156 | 0.081 | 0.166 | Arachidonic acid antagonist | 0.166 0.07 CID_32414 | CID_32414 | |
| 0.199 | 0.124 | 0.207 | DNA synthesis inhibitor | 0.207 0.112 CID_32414 | CID_32414 | |
| 0.151 | 0.076 | 0.163 | Interferon gamma antagonist | 0.163 0.063 CID_32414 | CID_32414 | |
| 0.113 | 0.043 | 0.113 | Prolactin inhibitor | 0.095 0.06 CID_32414 | ||
| 0.187 | 0.12 | 0.204 | Tumour necrosis factor alpha release inhibitor | 0.204 0.105 CID_32414 | CID_32414 | |
| 0.071 | 0.006 | 0.071 | Sigma 2 receptor antagonist | 0.034 0.015 CID_32414 | ||
| 0.112 | 0.047 | 0.112 | Antihistaminic | |||
| 0.111 | 0.049 | 0.111 | Anabolic | 0.109 0.051 CID_32414 | ||
| 0.185 | 0.124 | 0.185 | RNA-directed DNA polymerase inhibitor | 0.182 0.129 CID_32414 | ||
| 0.074 | 0.014 | 0.082 | Purinergic P2Y antagonist | 0.082 0.012 CID_32414 | CID_32414 | |
| 0.153 | 0.094 | 0.175 | Neurotensin receptor agonist | 0.175 0.055 CID_32414 | CID_32414 | |
| 0.077 | 0.019 | 0.077 | Potassium channel intermediate-conductance Ca-activated blocker | 0.063 0.035 CID_32414 | ||
| 0.168 | 0.11 | 0.169 | Insulin sensitizer | 0.169 0.109 CID_32414 | CID_32414 | |
| 0.119 | 0.061 | 0.119 | 5 Hydroxytryptamine 2B antagonist | |||
| 0.12 | 0.063 | 0.12 | Calcium channel N-type blocker | |||
| 0.124 | 0.067 | 0.13 | Aldehyde dehydrogenase inhibitor | 0.13 0.062 CID_32414 | CID_32414 | |
| 0.107 | 0.053 | 0.15 | UDP-glucose 4-epimerase inhibitor | 0.15 0.029 CID_32414 | CID_32414 | |
| 0.079 | 0.025 | 0.099 | Glutamate (mGluR6) antagonist | 0.099 0.011 CID_32414 | CID_32414 | |
| 0.099 | 0.045 | 0.116 | Ornithine decarboxylase inhibitor | 0.116 0.029 CID_32414 | CID_32414 | |
| 0.087 | 0.034 | 0.087 | Opioid delta receptor antagonist | 0.079 0.037 CID_32414 | ||
| 0.074 | 0.02 | 0.074 | Heme oxygenase stimulant | 0.073 0.021 CID_32414 | ||
| 0.099 | 0.048 | 0.099 | Histamine antagonist | |||
| 0.136 | 0.086 | 0.142 | Thiol protease inhibitor | 0.142 0.078 CID_32414 | CID_32414 | |
| 0.189 | 0.14 | 0.202 | Neuropeptide Y2 antagonist | 0.202 0.116 CID_32414 | CID_32414 | |
| 0.073 | 0.025 | 0.079 | Acyl-CoA dehydrogenase inhibitor | 0.079 0.023 CID_32414 | CID_32414 | |
| 0.059 | 0.012 | 0.071 | Substance P antagonist | 0.071 0.009 CID_32414 | CID_32414 | |
| 0.058 | 0.013 | 0.058 | Guanylate cyclase inhibitor | 0.054 0.017 CID_32414 | ||
| 0.105 | 0.061 | 0.115 | Toll-Like receptor 4 antagonist | 0.115 0.049 CID_32414 | CID_32414 | |
| 0.112 | 0.069 | 0.124 | TRPA1 agonist | 0.124 0.054 CID_32414 | CID_32414 | |
| 0.086 | 0.044 | 0.094 | Nicotinic alpha4beta2 receptor antagonist | 0.094 0.036 CID_32414 | CID_32414 | |
| 0.109 | 0.067 | 0.109 | GABA receptor agonist | 0.103 0.074 CID_32414 | ||
| 0.106 | 0.065 | 0.115 | Ferrochelatase inhibitor | 0.115 0.057 CID_32414 | CID_32414 | |
| 0.111 | 0.072 | 0.119 | Microtubule formation inhibitor | 0.119 0.062 CID_32414 | CID_32414 | |
| 0.064 | 0.025 | 0.064 | Nicotinic receptor alpha7 subunit antagonist | 0.055 0.035 CID_32414 | ||
| 0.099 | 0.061 | 0.099 | Sphingomyelinase inhibitor | |||
| 0.052 | 0.014 | 0.064 | GABA uptake inhibitor | 0.064 0.009 CID_32414 | CID_32414 | |
| 0.052 | 0.016 | 0.052 | Nerve growth factor antagonist | |||
| 0.087 | 0.052 | 0.087 | Histamine H2 receptor antagonist | |||
| 0.15 | 0.117 | 0.15 | DNA methylase inhibitor | |||
| 0.052 | 0.019 | 0.052 | Glutamate (mGluR group III) antagonist | 0.042 0.034 CID_32414 | ||
| 0.069 | 0.037 | 0.069 | 5 Hydroxytryptamine 3 agonist | |||
| 0.158 | 0.127 | 0.158 | Neurotrophic factor enhancer | |||
| 0.063 | 0.034 | 0.063 | Phosphodiesterase 1A inhibitor | |||
| 0.084 | 0.055 | 0.084 | Estrogen-related receptor beta agonist | |||
| 0.057 | 0.027 | 0.057 | 5 Hydroxytryptamine 4 antagonist | |||
| 0.091 | 0.063 | 0.091 | Potassium channel (Ca-activated) activator | 0.085 0.069 CID_32414 | ||
| 0.074 | 0.047 | 0.093 | Glycine receptor agonist | 0.093 0.026 CID_32414 | CID_32414 | |
| 0.094 | 0.067 | 0.094 | Creatine kinase inhibitor | 0.086 0.078 CID_32414 | ||
| 0.129 | 0.102 | 0.15 | Neuropeptide Y1 antagonist | 0.15 0.065 CID_32414 | CID_32414 | |
| 0.058 | 0.032 | 0.058 | Acetylcholine M2 receptor agonist | 0.052 0.039 CID_32414 | ||
| 0.129 | 0.103 | 0.129 | Pregnane X receptor agonist | |||
| 0.041 | 0.016 | 0.041 | Ceramide glucosyltransferase inhibitor | |||
| 0.054 | 0.03 | 0.064 | Neurokinin antagonist | 0.064 0.023 CID_32414 | CID_32414 | |
| 0.2 | 0.177 | 0.234 | Antithrombotic | 0.234 0.14 CID_32414 | CID_32414 | |
| 0.089 | 0.067 | 0.096 | Protein kinase C zeta inhibitor | 0.096 0.056 CID_32414 | CID_32414 | |
| 0.045 | 0.023 | 0.053 | Neurokinin 1 antagonist | 0.053 0.018 CID_32414 | CID_32414 | |
| 0.054 | 0.032 | 0.065 | Aconitate hydratase inhibitor | 0.065 0.022 CID_32414 | CID_32414 | |
| 0.042 | 0.021 | 0.042 | Retinoid X receptor antagonist | |||
| 0.05 | 0.029 | 0.05 | 11-Beta-hydroxysteroid dehydrogenase 1 inhibitor | |||
| 0.051 | 0.031 | 0.051 | Squalene epoxidase inhibitor | |||
| 0.038 | 0.018 | 0.038 | Retinoid X alpha receptor antagonist | |||
| 0.057 | 0.038 | 0.104 | Alcohol oxidase inhibitor | 0.104 0.017 CID_32414 | CID_32414 | |
| 0.056 | 0.038 | 0.057 | Phosphodiesterase 4C inhibitor | 0.057 0.038 CID_32414 | CID_32414 | |
| 0.109 | 0.091 | 0.181 | Toll-Like receptor 2 antagonist | 0.181 0.033 CID_32414 | CID_32414 | |
| 0.106 | 0.089 | 0.106 | Transcription factor STAT6 inhibitor | |||
| 0.066 | 0.05 | 0.067 | MDM2 inhibitor | 0.067 0.048 CID_32414 | CID_32414 | |
| 0.094 | 0.078 | 0.111 | Adenylate kinase inhibitor | 0.111 0.053 CID_32414 | CID_32414 | |
| 0.06 | 0.045 | 0.065 | Transcription factor AP-1 inhibitor | 0.065 0.037 CID_32414 | CID_32414 | |
| 0.031 | 0.016 | 0.031 | 11-Beta-hydroxysteroid dehydrogenase 2 inhibitor | |||
| 0.039 | 0.023 | 0.039 | Delayed rectifier potassium channel blocker | |||
| 0.048 | 0.033 | 0.048 | Cholesterol esterase inhibitor | |||
| 0.088 | 0.073 | 0.088 | Butyrylcholinesterase inhibitor | |||
| 0.072 | 0.058 | 0.072 | Phosphodiesterase VI inhibitor | |||
| 0.062 | 0.049 | 0.062 | Calcium channel P-type blocker | |||
| 0.037 | 0.024 | 0.037 | Retinoid X receptor agonist | |||
| 0.096 | 0.083 | 0.099 | Mucolytic | 0.099 0.078 CID_32414 | CID_32414 | |
| 0.049 | 0.037 | 0.055 | Lysophosphatidic acid 3 receptor antagonist | 0.055 0.028 CID_32414 | CID_32414 | |
| 0.027 | 0.015 | 0.028 | Lysophosphatidic acid receptor 1 agonist | 0.028 0.013 CID_32414 | CID_32414 | |
| 0.088 | 0.076 | 0.088 | Interleukin 1 beta converting enzyme inhibitor | |||
| 0.042 | 0.031 | 0.042 | Opioid kappa receptor agonist | |||
| 0.075 | 0.065 | 0.082 | Glycine receptor antagonist | 0.082 0.054 CID_32414 | CID_32414 | |
| 0.042 | 0.032 | 0.042 | Nicotinic receptor alpha3 subunit antagonist | 0.039 0.037 CID_32414 | ||
| 0.021 | 0.012 | 0.021 | Apolipoprotein B inhibitor | |||
| 0.121 | 0.112 | 0.143 | Hemostatic | 0.143 0.076 CID_32414 | CID_32414 | |
| 0.017 | 0.009 | 0.019 | NMDA receptor phencyclidine site antagonist | 0.019 0.007 CID_32414 | CID_32414 | |
| 0.054 | 0.046 | 0.054 | Pregnane X receptor antagonist | |||
| 0.023 | 0.015 | 0.023 | Leukotriene B4 receptor 2 antagonist | 0.02 0.018 CID_32414 | ||
| 0.061 | 0.054 | 0.061 | 5 Hydroxytryptamine 3A antagonist | |||
| 0.038 | 0.032 | 0.054 | Glutamate (mGluR1a) antagonist | 0.054 0.018 CID_32414 | CID_32414 | |
| 0.088 | 0.083 | 0.088 | Expectorant | |||
| 0.04 | 0.036 | 0.064 | GABA B receptor antagonist | 0.064 0.01 CID_32414 | CID_32414 | |
| 0.028 | 0.024 | 0.028 | Trypsin II inhibitor | |||
| 0.036 | 0.033 | 0.04 | Retinoic acid alpha receptor agonist | 0.04 0.026 CID_32414 | CID_32414 | |
| 0.044 | 0.042 | 0.044 | Benzodiazepine antagonist | |||
| 0.033 | 0.032 | 0.037 | Tryptophan 5 hydroxylase inhibitor | 0.037 0.02 CID_32414 | CID_32414 | |
| 0.079 | 0.078 | 0.104 | Protein kinase C delta inhibitor | 0.104 0.049 CID_32414 | CID_32414 | |
| 0.069 | 0.068 | 0.103 | Keratolytic | 0.103 0.029 CID_32414 | CID_32414 | |
| 0.06 | 0.06 | 0.08 | Protein kinase C alpha inhibitor | 0.08 0.034 CID_32414 | CID_32414 | |
| 0.085 | 0.086 | 0.087 | Bile acid receptor antagonist | 0.087 0.081 CID_32414 | CID_32414 | |
| 0.042 | 0.043 | 0.046 | Aldosterone antagonist | 0.046 0.036 CID_32414 | CID_32414 | |
| 0.084 | 0.086 | 0.091 | Electrolyte absorption antagonist | 0.091 0.073 CID_32414 | CID_32414 | |
| 0.012 | 0.014 | 0.014 | Cyclin D2 inhibitor | 0.014 0.008 CID_32414 | CID_32414 | |
| 0.057 | 0.059 | 0.074 | Protease 3C (Human rhinovirus) inhibitor | 0.074 0.033 CID_32414 | CID_32414 | |
| 0.087 | 0.089 | 0.09 | Carbonic anhydrase XV inhibitor | 0.09 0.082 CID_32414 | CID_32414 | |
| 0.038 | 0.044 | 0.043 | Glutamate (mGluR4) antagonist | 0.043 0.031 CID_32414 | CID_32414 | |
| 0.119 | 0.126 | 0.174 | Adenylate cyclase stimulant | 0.174 0.031 CID_32414 | CID_32414 | |
| 0.08 | 0.091 | 0.102 | Lanosterol 14 alpha demethylase inhibitor | 0.102 0.052 CID_32414 | CID_32414 | |
| 0.066 | 0.078 | 0.093 | Phosphodiesterase IV inhibitor | 0.093 0.051 CID_32414 | CID_32414 | |
| 0.044 | 0.058 | 0.054 | Alpha-mannosidase inhibitor | 0.054 0.036 CID_32414 | CID_32414 | |
| 0.044 | 0.06 | 0.056 | Mannitol-1-phosphate 5-dehydrogenase inhibitor | 0.056 0.039 CID_32414 | CID_32414 | |
| 0.039 | 0.057 | 0.049 | Diacylglycerol O-acyltransferase inhibitor | 0.049 0.037 CID_32414 | CID_32414 | |
| 0.03 | 0.05 | 0.037 | Acetyl-CoA transferase 1 inhibitor | 0.037 0.034 CID_32414 | CID_32414 | |
| 0.046 | 0.067 | 0.066 | Sphingosine 1-phosphate receptor 3 antagonist | 0.066 0.03 CID_32414 | CID_32414 | |
| 0.066 | 0.088 | 0.073 | Sphingosine 1-phosphate receptor antagonist | 0.073 0.061 CID_32414 | CID_32414 | |
| 0.066 | 0.089 | 0.072 | Viral attachment inhibitor | 0.072 0.07 CID_32414 | CID_32414 | |
| 0.018 | 0.042 | 0.026 | Nicotinic alpha4beta2 receptor agonist | 0.026 0.023 CID_32414 | CID_32414 | |
| 0.052 | 0.078 | 0.063 | Interferon inducer | 0.063 0.047 CID_32414 | CID_32414 | |
| 0.051 | 0.077 | 0.055 | Ryanodine receptor antagonist | 0.055 0.054 CID_32414 | CID_32414 | |
| 0.074 | 0.106 | 0.239 | GABA C receptor agonist | 0.239 0.015 CID_32414 | CID_32414 | |
| 0.061 | 0.093 | 0.074 | Interferon agonist | 0.074 0.063 CID_32414 | CID_32414 | |
| 0.069 | 0.102 | 0.084 | Triose-phosphate isomerase inhibitor | 0.084 0.068 CID_32414 | CID_32414 | |
| 0.042 | 0.075 | 0.066 | NMDA 2C receptor antagonist | 0.066 0.038 CID_32414 | CID_32414 | |
| 0.055 | 0.094 | 0.07 | Exportin-1 inhibitor | 0.07 0.043 CID_32414 | CID_32414 | |
| 0.06 | 0.101 | 0.093 | NMDA receptor antagonist | 0.093 0.052 CID_32414 | CID_32414 | |
| 0.053 | 0.097 | 0.073 | Phospholipase D inhibitor | 0.073 0.046 CID_32414 | CID_32414 | |
| 0.013 | 0.059 | 0.034 | Arginase inhibitor | 0.034 0.028 CID_32414 | CID_32414 | |
| 0.028 | 0.073 | 0.045 | Mannosidase inhibitor | 0.045 0.031 CID_32414 | CID_32414 | |
| 0.086 | 0.132 | 0.11 | Cytokine production inhibitor | 0.11 0.099 CID_32414 | CID_32414 | |
| 0.129 | 0.176 | 0.156 | Immunostimulant | 0.156 0.149 CID_32414 | CID_32414 | |
| 0.045 | 0.098 | 0.069 | Na+ K+ transporting ATPase inhibitor | 0.069 0.061 CID_32414 | CID_32414 | |
| 0.016 | 0.071 | 0.025 | Glutamate (mGluR1) agonist | 0.025 0.017 CID_32414 | CID_32414 | |
| 0.017 | 0.079 | 0.031 | Epoxide hydrolase 1 inhibitor | 0.031 0.02 CID_32414 | CID_32414 | |
| 0.08 | 0.143 | 0.125 | Cyclooxygenase 3 inhibitor | 0.125 0.072 CID_32414 | CID_32414 | |
| 0.038 | 0.108 | 0.064 | Phenylalanine 4-hydroxylase inhibitor | 0.064 0.053 CID_32414 | CID_32414 | |
| 0.133 | 0.205 | 0.169 | Calpain inhibitor | 0.169 0.15 CID_32414 | CID_32414 | |
| 0.03 | 0.104 | 0.054 | NMDA receptor glycine site agonist | 0.054 0.053 CID_32414 | CID_32414 | |
| 0.024 | 0.099 | 0.054 | Dihydroorotase inhibitor | 0.054 0.02 CID_32414 | CID_32414 | |
| 0.018 | 0.104 | 0.055 | Dopamine D5 agonist | 0.055 0.014 CID_32414 | CID_32414 | |
| 0.085 | 0.172 | 0.101 | Sphingosine 1-phosphate receptor 2 agonist | 0.101 0.1 CID_32414 | CID_32414 | |
| 0.058 | 0.146 | 0.083 | UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor | 0.083 0.076 CID_32414 | CID_32414 | |
| 0.108 | 0.2 | 0.166 | 3C-like protease (Human coronavirus) inhibitor | 0.166 0.079 CID_32414 | CID_32414 | |
| 0.151 | 0.25 | 0.209 | Insulysin inhibitor | 0.209 0.144 CID_32414 | CID_32414 | |
| 0.019 | 0.122 | 0.036 | Integrin alpha2 antagonist | 0.036 0.027 CID_32414 | CID_32414 | |
| 0.111 | 0.217 | 0.156 | Phospholipase C inhibitor | 0.156 0.095 CID_32414 | CID_32414 | |
| 0.05 | 0.177 | 0.085 | GABA B receptor agonist | 0.085 0.033 CID_32414 | CID_32414 | |
| 0.022 | 0.15 | 0.052 | Beta 1 adrenoreceptor antagonist | 0.052 0.044 CID_32414 | CID_32414 | |
| 0.071 | 0.2 | 0.117 | Peroxidase inhibitor | 0.117 0.103 CID_32414 | CID_32414 | |
| 0.03 | 0.173 | 0.062 | Beta adrenoreceptor antagonist | 0.062 0.051 CID_32414 | CID_32414 | |
| 0.057 | 0.199 | 0.105 | Bone formation stimulant | 0.105 0.1 CID_32414 | CID_32414 | |
| 0.025 | 0.174 | 0.04 | Alpha 1L adrenoreceptor agonist | 0.04 0.037 CID_32414 | CID_32414 | |
| 0.16 | 0.32 | 0.214 | Ca2+/calmodulin-dependent kinase IV inhibitor | 0.214 0.128 CID_32414 | CID_32414 | |
| 0.057 | 0.225 | 0.081 | 3C-Like protease (SARS coronavirus) inhibitor | 0.081 0.066 CID_32414 | CID_32414 | |
| 0.123 | 0.317 | 0.172 | Nitric-oxide synthase stimulant | 0.172 0.147 CID_32414 | CID_32414 | |
| 0.007 | 0.234 | 0.07 | 5 Hydroxytryptamine 2C agonist | 0.07 0.015 CID_32414 | CID_32414 | |
| 0.015 | 0.286 | 0.049 | Phenylethanolamine N methyltransferase inhibitor | 0.049 0.015 CID_32414 | CID_32414 | |
| 0.012 | 0.421 | 0.054 | Myc inhibitor | 0.054 0.038 CID_32414 | CID_32414 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |